Patents by Inventor Thomas Janicki

Thomas Janicki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058032
    Abstract: Systems and methods to assist a practitioner to confirm location of a distal tip of a needle within a patient include confirming tactile feedback from a needle insertion to a point of loss of resistance of fluid flow and by viewing a display showing color of a tissue plane at the distal tip of the needle at the point of loss of resistance.
    Type: Application
    Filed: November 2, 2023
    Publication date: February 22, 2024
    Applicant: Lumoptik, Inc.
    Inventors: Donald J. Verlee, Thomas Janicki
  • Patent number: 11446055
    Abstract: Systems and methods to assist a practitioner to confirm location of a distal tip of a needle within a patient include confirming tactile feedback from a needle insertion to a point of loss of resistance of fluid flow and by viewing a display showing color of a tissue plane at the distal tip of the needle at the point of loss of resistance.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: September 20, 2022
    Assignee: Lumoptik, Inc.
    Inventors: Donald J Verlee, Thomas Janicki
  • Publication number: 20140303494
    Abstract: A system and device to determine the location of a needle as it penetrates through a tissue and into a desired site, such as the epidural space, are described. The system (1000) contains a light guide (1020), a light source (1040), a light sensor (1050), and a logic unit (1060). When the tip of the needle (1010) traverses the relatively dense Ligamantum Flavum, the reflecting plane of the ligament is positioned at or near zero distance relative to the tip of the device. Once the tip enters a less dense epidural space the distance to the reflecting plane becomes greater than zero thus producing a drop in intensity of the reflected light. That drop in the intensity of the reflected light is measured by the light sensor and interpreted by a logic unit to be consistent with entry into the epidural space, allowing the system to provide a signal indicating entry into the epidural space.
    Type: Application
    Filed: October 15, 2012
    Publication date: October 9, 2014
    Applicant: LUMOPTIK LLC
    Inventors: Thomas I. Janicki, Arthur Anthony Janicki, Oscar Thomas Janicki
  • Publication number: 20140276082
    Abstract: An ultrasound probe system for guiding introduction of an instrument into a patient includes a disk having a surface and an open channel passing axially through the disk and at least two ultrasound transducer elements disposed on the surface of the disk in a parallel arrangement. The open channel is configured to receive the instrument therethrough to permit alignment of the instrument with respect to the disk. Each of the ultrasound transducer elements is configured to transmit and receive ultrasonic waves for detecting an anatomical structure. A graphical representation of at least a portion of the anatomical structure can be provided for guiding the introduction or insertion of the instrument into the anatomical structure.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: LUMOPTIK LLC
    Inventors: Arthur A. Janicki, Oscar Thomas Janicki
  • Patent number: 8226972
    Abstract: Drug delivery compositions which are suitable for vaginal administration for the treatment of diseases and disorders in the urogenital tract are described. The compositions may be in the form of a tablet, liquid suspension or dispersion, dried powder, topical ointment, cream, foam, suppository, or aerosol. The drug delivery compositions are administered directly to the vagina and do not require the use of a solid device. This method of administration reduces the systematic levels of the drugs.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: July 24, 2012
    Assignee: FemmePharma Holding Company, Inc.
    Inventors: Gerianne Tringali DiPiano, John A. Ziemniak, Thomas Janicki
  • Publication number: 20030143278
    Abstract: Drug delivery compositions which are suitable for vaginal administration for the treatment of diseases and disorders in the urogenital tract are described. The compositions may be in the form of a tablet, liquid suspension or dispersion, dried powder, topical ointment, cream, foam, suppository, or aerosol.
    Type: Application
    Filed: December 19, 2002
    Publication date: July 31, 2003
    Applicant: FemmePharma, Inc.
    Inventors: Gerianne Tringali DiPiano, John A. Ziemniak, Thomas Janicki